Simulation-Based Caregiver Education for Cancer Support
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether an education and support program can boost caregivers' confidence in caring for someone with cancer. It tests various methods of providing education and support to determine which are most beneficial for caregivers. The trial includes one-on-one teaching sessions for caregivers during the patient's radiation treatments, followed by a call two weeks later. Patients with specific cancer types who are beginning radiation therapy and have a family caregiver offering daily assistance are well-suited for this trial. As an unphased trial, it provides caregivers a unique chance to enhance their skills and confidence in a supportive setting.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, caregivers undergoing active cancer treatment are excluded, except for those on hormonal treatment.
What prior data suggests that this education and support program is safe for caregivers?
Research shows that simulation-based caregiving skills training is generally safe for caregivers. Studies have found that this program is not only safe but also appreciated and helpful for caregivers of cancer patients. Caregivers reported feeling more confident in their abilities after the training sessions. No serious negative effects were reported, indicating that the program is well-tolerated and should not pose any safety risks to participants.12345
Why are researchers excited about this trial?
Researchers are excited about the simulation-based caregiver education because it offers a fresh approach to supporting cancer patients during their treatment. Unlike typical caregiver programs that might rely on generalized information or sporadic support, this method provides personalized, one-on-one teaching sessions tailored specifically to the caregiver's needs. These sessions are integrated with the patient's radiation treatment schedule, ensuring timely and relevant guidance. Additionally, a unique follow-up phone call two weeks post-treatment helps reinforce the learning and address any lingering questions or challenges. This hands-on, continuous support system has the potential to significantly enhance the caregiver's ability to provide effective care, ultimately benefiting the patient's overall treatment experience.
What evidence suggests that this education and support program is effective for caregivers of cancer patients?
Research has shown that training programs using simulations can be very effective for caregivers. In this trial, participants in the intervention arm will receive simulation-based caregiving skills training through three in-person, one-on-one teaching sessions, followed by a telephone booster contact. Studies have found that caregivers consider these programs safe, practical, and helpful. They report feeling more prepared and confident in their caregiving skills after participating. This training often includes important tasks like feeding and hygiene, which are essential for patient care. Caregivers also appreciate the support and information provided during these sessions. Overall, simulation-based training empowers caregivers, making them feel more capable of handling the challenges of caring for a loved one with cancer.12367
Who Is on the Research Team?
Susan Mazanec, PhD
Principal Investigator
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for caregivers of cancer patients who are starting their first radiation therapy. The patient must have certain types of cancer like rectal, esophageal, or specific stages of lung and head/neck cancers. Caregivers should be the primary support person but can't participate if they're receiving active cancer treatment themselves (except hormonal), or if the patient is in hospice care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Three in-person, one-on-one teaching sessions with the caregiver during radiation treatments, followed by a telephone booster contact 2 weeks post-treatment
Follow-up
Participants are monitored for caregiver and patient outcomes, including HRQOL and anxiety, at 4 and 20 weeks post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- One-on-one teaching sessions
- Telephone booster contact
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Comprehensive Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator